Orion Market Research (OMR)
recently published a market research report on the global Nasopharyngeal Cancer market. According to OMR analysis,
the global nasopharyngeal cancer market is estimated to grow at a significant CAGR during the
forecast period (2018-2023). Rising incidences of nasopharyngeal cancer across
the globe and high tobacco and alcohol consumption are some major factors
driving the growth of the market. Furthermore, high intake of salt-preserved
food and exposure to Epstein-Barr Virus (EBV) are further contributing to the growth
of the market.
A full report of global nasopharyngeal cancer market
is available at
Furthermore, the global nasopharyngeal
cancer market is segmented on the basis of cancer type, diagnosis method and therapy.
The report provides detailed & insightful chapters which include market
overview, key findings, strategic recommendations, market estimations, market
determinants, key company analysis, market insights, company profiling, market
segmentation, geographical analysis, analyst insights and predictive analysis
of the market.
Market Segmentation
1.
Global Nasopharyngeal Cancer Market by Cancer Type
·
Keratinising Squamous Cell Carcinoma
·
Non-Keratinising Squamous Cell Carcinoma
·
Undifferentiated Carcinomas
·
Others (Adenocarcinoma and Adenoid Cystic
Carcinomas)
2.
Global Nasopharyngeal Cancer Market by Diagnosis
Method
·
Initial Diagnosis
o Nasendoscopy
o Panendoscopy
o Fine Needle
Aspiration/Needle Biopsy
·
Advanced Diagnosis
o CT Scan
o PET Scan
o MRI Scan
o Bone Scan
3.
Global Nasopharyngeal Cancer Market by Therapy
·
Chemotherapy
·
Immunotherapy
·
Surgery
·
Targeted Therapy
Regions Covered
•
North America (the US and Canada)
•
Europe (UK, Germany, France,
Spain, and Italy)
•
Asia-Pacific (China, India,
South Korea, and Japan)
•
Rest of the World (Middle East
& Africa and Latin America)
Company
Profiles
·
BioDiem Ltd.
·
Bristol-Myers Squibb Co.
·
Cyclacel Pharmaceuticals, Inc.
·
Eli Lilly And Co.
·
GlaxoSmithKline PLC
·
Merck KGaA
·
Novartis International AG
·
Ono Pharmaceutical Co., Ltd.
·
Sanofi SA
·
TheraVectys SAS
The key objectives of the Nasopharyngeal Cancer study:
· To analyze the Nasopharyngeal
Cancer Market size (values and volume) by segments with historical data
of 2017 and 2018 and forecast to 2025.
·
To study the key factors influencing the growth
of the market.
·
Focuses on the key leaders to define and analyze
the sales volume, value, share, competitive landscapes, SWOT analysis, and
development plans.
·
To analyze the Nasopharyngeal
Cancer Market growth, global trends, future prospectus and contribution
to the market.
Related Reports:
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404
